AngioDynamics (Nasdaq: ANGO) reported earnings on Jan. 3. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Nov. 30 (Q2), AngioDynamics met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share contracted significantly.

Margins dropped across the board.

Revenue details
 AngioDynamics recorded revenue of $87.0 million. The five analysts polled by S&P Capital IQ expected net sales of $87.2 million on the same basis. GAAP reported sales were 50% higher than the prior-year quarter's $58.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.10. The six earnings estimates compiled by S&P Capital IQ anticipated $0.09 per share. GAAP EPS of $0.06 for Q2 were 33% lower than the prior-year quarter's $0.09 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 50.7%, 650 basis points worse than the prior-year quarter. Operating margin was 8.5%, 70 basis points worse than the prior-year quarter. Net margin was 2.3%, 170 basis points worse than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $87.8 million. On the bottom line, the average EPS estimate is $0.09.

Next year's average estimate for revenue is $355.7 million. The average EPS estimate is $0.40.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 99 members out of 113 rating the stock outperform, and 14 members rating it underperform. Among 37 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 31 give AngioDynamics a green thumbs-up, and six give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on AngioDynamics is hold, with an average price target of $13.50.

Is AngioDynamics the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.